Dr. Ronald J. Poblete, MD

Dr. Poblete practices at North Jersey Community Research Initiative in Newark, New Jersey.

Dr. Poblete's NPI, 1740271998, was assigned on November 4, 2005. Dr. Poblete holds New Jersey license 25MA05479500.

Dr. Poblete's primary practice is North Jersey Community Research Initiative, at 393 Central Avenue, Newark, NJ 07103. The practice phone is (973) 483-3444.

Dr. Poblete's primary practice is North Jersey Community Research Initiative in Newark, New Jersey. Dr. Poblete is also affiliated with St. Joseph's University Medical Center. The medical group on file is NJCRI Physician's Group. Dmand AI also links Dr. Poblete to 2 more hospitals, 1 physician office and 1 group practice or clinic, each named with a free account. Dr. Poblete's employer is on file too: a behavioral health center.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Poblete practices, 6 sites in all. Vendor and product names are available with a free account.

Infectious disease is Dr. Poblete's primary specialty in the NPI Registry, under taxonomy code 207RI0200X. Dr. Poblete is licensed in New Jersey.

CMS data shows 1,869 Medicare services from Dr. Poblete across 3 procedure codes in 2024, for 205 Medicare patients. Medicare paid $135,938 for them.

CMS counts 205 Medicare patients who saw Dr. Poblete in 2024. The largest group is 75 to 84, with 69 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 45% are also on Medicaid. Their average risk score is 3.39, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Poblete's median patient age at 52, with 34% women.

In 2024, Dr. Poblete wrote 1,590 Medicare Part D claims for 114 patients. 54% of them were for generic drugs. CMS names the drug for 1,336 of them, across 34 drugs with 11 or more claims each, at $2,445,022 in total drug cost. In 2023, CMS named 1,257 claims across 37 drugs.

Dr. Poblete accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Poblete as offering telehealth.

CMS Open Payments shows 1,064 general payments to Dr. Poblete from 20 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 37% of the total. ViiV Healthcare Company paid the most, $19,910.